Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (chlamydia and gonorrhea). The Company's first FDA-approved product, Phexxi® (lactic acid, citric acid and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of 12 pre-filled applicators and is applied 0-60 minutes before each act of sex.
To find out more visit www.evofem.com and www.phexxi.com
Phexxi® is a registered trademark of Evofem Biosciences, Inc.
For more information, please contact:
Jaspreet Bakshi
[email protected]
(949) 973-5215
Robin Geyer
[email protected]
(209) 761-0010